US20090220523A1 - Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditions - Google Patents

Compositions and methods for the treatment and prevention of fibrotic, inflammatory and neovascularization conditions Download PDF

Info

Publication number
US20090220523A1
US20090220523A1 US12/091,890 US9189006A US2009220523A1 US 20090220523 A1 US20090220523 A1 US 20090220523A1 US 9189006 A US9189006 A US 9189006A US 2009220523 A1 US2009220523 A1 US 2009220523A1
Authority
US
United States
Prior art keywords
method
s1p
immune
lpa
derived moiety
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/091,890
Inventor
Roger A. Sabbadini
William A. Garland
Glenn L. Stoller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Apollo Endosurgery Inc
Original Assignee
Apollo Endosurgery Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US11261935 priority Critical
Priority to US11/261,935 priority patent/US7794713B2/en
Application filed by Apollo Endosurgery Inc filed Critical Apollo Endosurgery Inc
Priority to US12/091,890 priority patent/US20090220523A1/en
Priority to PCT/US2006/042027 priority patent/WO2007053447A2/en
Assigned to LPATH THERAPEUTICS, INC. reassignment LPATH THERAPEUTICS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: STOLLER, GLENN L., GARLAND, WILLIAM A., SABBADINI, ROGER A.
Assigned to LPATH, INC. reassignment LPATH, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LPATH THERAPEUTICS, INC.
Publication of US20090220523A1 publication Critical patent/US20090220523A1/en
Application status is Abandoned legal-status Critical

Links